Cargando…

Patient-derived xenografts and organoids model therapy response in prostate cancer

Therapy resistance and metastatic processes in prostate cancer (PCa) remain undefined, due to lack of experimental models that mimic different disease stages. We describe an androgen-dependent PCa patient-derived xenograft (PDX) model from treatment-naïve, soft tissue metastasis (PNPCa). RNA and who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karkampouna, Sofia, La Manna, Federico, Benjak, Andrej, Kiener, Mirjam, De Menna, Marta, Zoni, Eugenio, Grosjean, Joël, Klima, Irena, Garofoli, Andrea, Bolis, Marco, Vallerga, Arianna, Theurillat, Jean-Philippe, De Filippo, Maria R., Genitsch, Vera, Keller, David, Booij, Tijmen H., Stirnimann, Christian U., Eng, Kenneth, Sboner, Andrea, Ng, Charlotte K. Y., Piscuoglio, Salvatore, Gray, Peter C., Spahn, Martin, Rubin, Mark A., Thalmann, George N., Kruithof-de Julio, Marianna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892572/ https://www.ncbi.nlm.nih.gov/pubmed/33602919 http://dx.doi.org/10.1038/s41467-021-21300-6

Ejemplares similares

Bladder cancer organoids as a functional system to model different disease stages and therapy response
por: Minoli, Martina, et al.
Publicado: (2023)

miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo
por: Kiener, Mirjam, et al.
Publicado: (2019)

Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma Signatures
por: Karkampouna, Sofia, et al.
Publicado: (2020)

A Multidisciplinary Review of the Roles of Cripto in the Scientific Literature Through a Bibliometric Analysis of its Biological Roles
por: Rodrigues Sousa, Elisa, et al.
Publicado: (2020)

ALK1Fc Suppresses the Human Prostate Cancer Growth in in Vitro and in Vivo Preclinical Models
por: Astrologo, Letizia, et al.
Publicado: (2017)

Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification
por: Zoni, Eugenio, et al.
Publicado: (2019)

The Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis
por: Bonollo, Francesco, et al.
Publicado: (2020)

Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity
por: La Manna, Federico, et al.
Publicado: (2020)

Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity
por: La Manna, Federico, et al.
Publicado: (2021)

Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression
por: Bolis, Marco, et al.
Publicado: (2021)

Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label therapy
por: Hirt, Christian K., et al.
Publicado: (2022)

Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications
por: Minoli, Martina, et al.
Publicado: (2020)

Whence CRIPTO: The Reemergence of an Oncofetal Factor in ‘Wounds’ That Fail to Heal
por: Freeman, David W., et al.
Publicado: (2021)

Tumor Organoids as a Research Tool: How to Exploit Them
por: Booij, Tijmen H., et al.
Publicado: (2022)

Editorial: Personalized Medicine for Urological Cancers: Targeting Cancer Metabolism
por: Gunter, Jennifer H., et al.
Publicado: (2022)

miR-25, integrin and cancer invasiveness
por: Zoni, Eugenio, et al.
Publicado: (2015)

Neuroendocrine Differentiation in Metastatic Conventional Prostate Cancer Is Significantly Increased in Lymph Node Metastases Compared to the Primary Tumors
por: Genitsch, Vera, et al.
Publicado: (2017)

miR-221 Augments TRAIL-Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1
por: Krebs, Markus, et al.
Publicado: (2019)

Epithelial Plasticity in Cancer: Unmasking a MicroRNA Network for TGF-β-, Notch-, and Wnt-Mediated EMT
por: Zoni, Eugenio, et al.
Publicado: (2015)

CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer
por: Zoni, E, et al.
Publicado: (2017)

Oncofetal Protein CRIPTO Is Involved in Wound Healing and Fibrogenesis in the Regenerating Liver and Is Associated with the Initial Stages of Cardiac Fibrosis
por: Karkampouna, Sofia, et al.
Publicado: (2021)

DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations
por: Gallon, John, et al.
Publicado: (2023)

3D Cell-Based Assays for Drug Screens: Challenges in Imaging, Image Analysis, and High-Content Analysis
por: Booij, Tijmen H., et al.
Publicado: (2019)

Prediction of Biochemical Recurrence Based on Molecular Detection of Lymph Node Metastasis After Radical Prostatectomy
por: Özdemir, Berna C., et al.
Publicado: (2022)

Connective Tissue Degeneration: Mechanisms of Palmar Fascia Degeneration (Dupuytren’s Disease)
por: Karkampouna, S., et al.
Publicado: (2016)

Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancer
por: Bernasocchi, Tiziano, et al.
Publicado: (2021)

The Genomic Landscape of Serrated Lesion of the Colorectum: Similarities and Differences With Tubular and Tubulovillous Adenomas
por: Tornillo, Luigi, et al.
Publicado: (2021)

TIP5 primes prostate luminal cells for the oncogenic transformation mediated by PTEN-loss
por: Pietrzak, Karolina, et al.
Publicado: (2020)

Correction to: Store-Operated Ca(2+) Entry as a Prostate Cancer Biomarker — a Riddle with Perspectives
por: Kappel, Sven, et al.
Publicado: (2018)

Store-Operated Ca(2+) Entry as a Prostate Cancer Biomarker — a Riddle with Perspectives
por: Kappel, Sven, et al.
Publicado: (2017)

Alterations in homologous recombination repair genes in prostate cancer brain metastases
por: Rodriguez-Calero, Antonio, et al.
Publicado: (2022)

Nutritional Challenges in Patients with Advanced Liver Cirrhosis
por: Stirnimann, Jessica, et al.
Publicado: (2019)

Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer
por: Tschui, J., et al.
Publicado: (2015)

Guidance of adjuvant instillation in intermediate-risk non-muscle invasive bladder cancer by drug screens in patient derived organoids: a single center, open-label, phase II trial
por: Seiler, Roland, et al.
Publicado: (2023)

Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity
por: Cyrta, Joanna, et al.
Publicado: (2020)

A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection
por: Laise, Pasquale, et al.
Publicado: (2022)

A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection
por: Laise, Pasquale, et al.
Publicado: (2022)

Urethral strictures after radiation therapy for prostate cancer
por: Moltzahn, Felix, et al.
Publicado: (2016)

Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors
por: Alaimo, Alessandro, et al.
Publicado: (2020)

Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19
por: Kiener, Mirjam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lh2e5oes3lh9m6t7ndu0uuaugc